Previous Close | 0.4200 |
Open | 0.4200 |
Bid | 0.0000 |
Ask | 0.3300 |
Strike | 121.00 |
Expire Date | 2024-06-14 |
Day's Range | 0.4200 - 0.4200 |
Contract Range | N/A |
Volume | |
Open Interest | 31 |
Eli Lilly may be riding high on its diabetes and weight-loss treatments Mounjaro and Zepbound — which Wall Street estimates could net the company $13.5 billion in 2024 — but the success comes with ongoing criticism about pricing and access.
These five companies may offer higher earnings and return potential with lower risk. Two Leaderboard stocks included.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.